Financial statements Citipharm Spółka Z Ograniczoną Odpowiedzialnoścą
Balance sheet data of CITIPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCĄ
Year
|
2017
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 1 128 504,80 | 1 167 420,24 | 756 306,70 | 769 295,43 | 1 078 089,22 | 1 094 781,00 |
A. Fixed assets | 0,00 | 22 843,99 | 13 706,39 | 4 568,79 | 0,00 | 0,00 |
B. Current assets | 1 128 504,80 | 1 144 576,25 | 742 600,31 | 764 726,64 | 1 078 089,22 | 1 094 781,00 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 1 128 504,80 | 1 167 420,24 | 756 306,70 | 769 295,43 | 1 078 089,22 | 1 094 781,00 |
A. Equity | 327 793,16 | 545 804,60 | 257 404,68 | 216 687,01 | 203 691,09 | 101 660,14 |
B. Liabilities and provisions for liabilities | 800 711,64 | 621 615,64 | 498 902,02 | 552 608,42 | 874 398,13 | 993 120,86 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 800 711,64 | 621 615,64 | 498 359,14 | 552 608,42 | 874 398,13 | 993 120,86 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.